An in-depth look to PELL BIO-MED TECHNOLOGY CO LTD operating, investing, and financing activities

6949 free cash flow for Q1 24 is -56.37 M TWD. For 2023, 6949 free cash flow was -196.32 M TWD and operating cash flow was -179.84 M TWD.